A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C

800 mg three times daily for 24, 32 or 44 weeks

180 mcg subcutaneously once a week for 24, 32 or 44 weeks

180 mcg subcutaneously once a week for 4 weeks

1000 mg or 1200 mg orally once a day for 24, 32 or 44 weeks

1000 mg or 1200 mg orally once a day for 4 weeks